Detalhe da pesquisa
1.
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 22(1): 22-33.e6, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716619
2.
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.
Ther Drug Monit
; 44(2): 290-300, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387220
3.
A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence.
Scand J Gastroenterol
; 57(3): 274-281, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779308
4.
Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics.
Scand J Gastroenterol
; 57(9): 1051-1057, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412932
5.
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Scand J Gastroenterol
; 55(8): 884-890, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631131
6.
Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study.
Scand J Gastroenterol
; 53(8): 930-937, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987951
7.
Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy.
Am J Gastroenterol
; 110(11): 1526-32, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26032156
8.
High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors.
BMC Cancer
; 15: 35, 2015 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655188
9.
Identifying and understanding disease burden in patients with inflammatory bowel disease.
BMJ Open Gastroenterol
; 9(1)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302557
10.
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
NEJM Evid
; 1(8): EVIDoa2200061, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319804
11.
Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 23(7): 1210-1217, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445244
12.
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease.
Medicine (Baltimore)
; 95(16): e3417, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27100432
13.
Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial.
BMJ Open
; 4(12): e005887, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25524543